Olema Pharmaceuticals (OLMA) Shares Outstanding (2020 - 2026)
Olema Pharmaceuticals (OLMA) posted quarterly Shares Outstanding (Entity) of $87.3 million for Q1 2026, up 2.23% year-over-year from $85.4 million in Q1 2025, and up 7.32% quarter-over-quarter from $81.4 million in Q4 2025.
Olema Pharmaceuticals (OLMA) Shares Outstanding (2020 - 2026) Analysis & Trends
Olema Pharmaceuticals (OLMA) has reported Shares Outstanding (Entity) for 7 consecutive years, with $87.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 2.23% year-over-year to $87.3 million; the TTM figure through Mar 2026 stood at $87.3 million (up 2.23% YoY), while the FY2025 annual figure was $81.4 million, up 38.53% from the prior year.
- Shares Outstanding (Entity) grew to $87.3 million in Q1 2026 per OLMA's latest filing, from $81.4 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $87.3 million in Q1 2026 and bottomed at $39.9 million in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $56.0 million across 5 years, with a median of $55.9 million in 2024.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) increased 1.02% — and 2025, when it soared 52.91%.
- Olema Pharmaceuticals' Shares Outstanding (Entity) stood at $40.3 million in 2022, then rose by 12.31% to $45.2 million in 2023, then increased by 29.83% to $58.7 million in 2024, then surged by 38.53% to $81.4 million in 2025, then increased by 7.32% to $87.3 million in 2026.
- Business Quant data shows OLMA's Shares Outstanding (Entity) at $87.3 million in Q1 2026, $81.4 million in Q4 2025, and $68.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Olema Pharmaceuticals | 930.10 Mn | 930.10 Mn | - | 104.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 104.45 Mn |
| Mar 31, 2026 | 102.80 Mn |
| Dec 31, 2025 | 87.01 Mn |
| Sep 30, 2025 | 85.73 Mn |
| Jun 30, 2025 | 85.50 Mn |
| Mar 31, 2025 | 85.43 Mn |
| Dec 31, 2024 | 58.74 Mn |
| Sep 30, 2024 | 57.26 Mn |
| Jun 30, 2024 | 56.28 Mn |
| Mar 31, 2024 | 55.57 Mn |
| Dec 31, 2023 | 45.25 Mn |
| Sep 30, 2023 | 44.98 Mn |
| Jun 30, 2023 | 40.72 Mn |
| Mar 31, 2023 | 40.35 Mn |
| Dec 31, 2022 | 40.00 Mn |
| Sep 30, 2022 | 40.04 Mn |
| Jun 30, 2022 | 39.92 Mn |
| Mar 31, 2022 | 39.83 Mn |
| Dec 31, 2021 | 39.52 Mn |
| Sep 30, 2021 | 39.61 Mn |